Eastwood Bio-Medical Canada IncTSXV:EBM
- LAST PRICE0.7500
- TODAY'S CHANGE (%)0.0700 (10.2941%)
- Bid / Lots0.5500/ 2
- Ask / Lots0.9000/ 8
- Open / Previous Close0.6500 / 0.6800
- Day Range
- 52 Week Range
- Volume6,030
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | EBM |
|---|---|---|
| 09:32 ET | 1000 | 0.65 |
| 09:50 ET | 4000 | 0.7 |
| 09:51 ET | 1000 | 0.75 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Eastwood Bio-Medical Canada Inc | 51.7M | -106.7x | --- |
Simply Solventless Concentrates Ltd | 51.3M | 11.2x | --- |
Red Light Holland Corp | 17.9M | -2.5x | --- |
Pharmacielo Ltd | 14.1M | -0.9x | --- |
Orion Nutraceuticals Inc | 13.0M | -219.8x | --- |
Nass Valley Gateway Ltd | 10.9M | -6.3x | --- |
Company Information
Eastwood Bio-Medical Canada Inc. is a Canada-based company, which is engaged in marketing and distributing natural health products in North America. The Company is a licensed distributor of the Eleotin line of products, which include formulations based on natural ingredients that are presented in tea or capsule forms. The Company's Eleotin products include natural remedies for certain metabolic disorders such as blood glucose disorders, hypertension and obesity, and can be used as a dietary supplement. Its licensed products which have secured Health Canada product license numbers include Eleotin A 700, Eleotin AL88, Eleotin Cal20, Eleotin V3D, Eleotin G2000, Eleotin H55, and Eleotin Zn330. Additionally, Eleotin Bentley and Eleotin LBM have received Health Canada product license numbers. The Eleotin Bentley is used to promote healthy glucose levels. The Eleotin LBM is recommended for hypertension relief. The Company markets its products in Asia, United States and Canada.
Contact Information
- Headquarters
- 1130 - 4871 Shell RoadRICHMOND, BC, Canada V6X 3Z6
- Phone
- 604-247-2100
- Fax
- 604-247-2101
Executives
- President, Chief Financial Officer, Corporate Secretary, Director
- Yunji Kim
- Chief Executive Officer, Director
- Youngsoo Kim
- Independent Director
- Marcus Kuypers
- Independent Director
- Ian Mallmann
- Independent Director
- Terrance Owen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $51.7M |
|---|---|
Revenue (TTM) | $653.5K |
Shares Outstanding | 68.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.05 |
EPS | $-0.01 |
Book Value | $-0.01 |
P/E Ratio | -106.7x |
Price/Sales (TTM) | 79.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -74.11% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
